Company Filing History:
1 out of 5,309 
1 out of 894 
Years Active: 2020
Title: Innovator Jinte Middeldorp: Advancing Treatments for Aging-Associated Conditions
Jinte Middeldorp, an innovative inventor based in Utrecht, NL, has made significant strides in the field of medical treatments for aging-associated conditions. With a focus on cognitive impairment, his work aims to enhance the quality of life for individuals facing the challenges of aging.
Latest Patents
Middeldorp holds a patent for "Methods and Compositions for Treating Aging-Associated Conditions." This patent outlines novel methods and compositions designed to treat subjects suffering from cognitive impairment conditions related to aging. A key aspect of his invention includes administering a young plasma-comprising blood product to those at risk or currently affected by these conditions, aiming to restore cognitive function and improve overall well-being. Additionally, the patent covers compositions and kits that facilitate the implementation of these methods.
Career Highlights
Throughout his career, Jinte Middeldorp has been associated with esteemed institutions including Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. His experiences at these organizations have contributed to his research and innovative approaches in the medical field.
Collaborations
Middeldorp has collaborated with notable figures in research and innovation, such as Anton Wyss-Coray and Saul A. Villeda. These partnerships have proven beneficial in advancing understanding and approaches to aging and cognitive health, yielding promising results for future exploration.
Conclusion
In summary, Jinte Middeldorp stands out as a dedicated inventor in the realm of aging-associated condition treatments. His innovative patent not only provides promising methods for enhancing cognitive health but also reflects the potential of collaboration in driving progress in medical science. As research advances, Jinte Middeldorp's contributions are likely to play a pivotal role in shaping the future of treatments for aging-related ailments.